Background: The absence of efficient inhibitors for diabetic kidney disease (DKD) progression reflects the gaps in our understanding of DKD molecular pathogenesis.
Methods: A comprehensive proteomic analysis was performed on the glomeruli and kidney cortex of diabetic mice with the subsequent validation of findings in human biopsies and omics datasets, aiming to better understand the underlying molecular biology of early DKD development and progression.
Results: LC-MS/MS was employed to analyze the kidney proteome of 2 DKD models: Ins2Akita (early and late DKD) and db/db mice (late DKD). The abundance of detected proteins was defined. Pathway analysis of differentially expressed proteins in the early and late DKD versus the respective controls predicted dysregulation in DKD hallmarks (peroxisomal lipid metabolism and β-oxidation), supporting the functional relevance of the findings. Comparing the observed protein changes in early and late DKD, the consistent upregulation of 21 and downregulation of 18 proteins was detected. Among these were downregulated peroxisomal and upregulated mitochondrial proteins. Tissue sections from 16 DKD patients were analyzed by IHC confirming our results.
Conclusion: Our study shows an extensive differential expression of peroxisomal proteins in the early stages of DKD that persists regardless of the disease severity, providing new perspectives and potential markers of diabetic kidney dysfunction.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869654 | PMC |
| http://dx.doi.org/10.3390/biomedicines10020216 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: DNA methylation differences are associated with kidney function and diabetic kidney disease (DKD), but prospective studies are scarce. Therefore, we aimed to study DNA methylation in a prospective setting in the Finnish Diabetic Nephropathy Study type 1 diabetes (T1D) cohort.
Methods: We analysed baseline blood sample-derived DNA methylation (Illumina's EPIC array) of 403 individuals with normal albumin excretion rate (early progression group) and 373 individuals with severe albuminuria (late progression group) and followed-up their DKD progression defined as decrease in eGFR to <60 mL/min/1.
The Retinal Blood Flow Density Is Related to the Pathological Severity of Diabetic Kidney Disease.
Ophthalmic Res
October 2024
Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Introduction: This study aimed to investigate the correlation between fundus blood flow parameters and the severity of pathological biopsy in patients with diabetic kidney disease (DKD).
Methods: Data of patients with type 2 diabetes mellitus who completed renal pathology biopsies and optical coherence tomography angiography (OCTA) examinations, including renal function, 24-h urine protein quantification, and macular flow imaging, were collected. DKD pathology biopsies were graded as stages 1-4, and differences and correlations of the parameters were compared between groups.
Chronic Kidney Disease and Charcot Neuro-Osteoarthropathy of Foot in Diabetes.
Int J Low Extrem Wounds
July 2024
Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Article Synopsis
- Charcot neuro-osteoarthropathy (CNO) is a serious condition in diabetes that can lead to severe complications like fractures and higher death rates, and its prevalence with chronic kidney disease (CKD) is not well studied.
- In a study of 493 patients with CNO, 43.7% had CKD, and those with CKD had a significantly lower chance of achieving remission of CNO symptoms compared to those without CKD.
- The study found that patients with CNO and CKD had a higher all-cause mortality rate over four years, indicating a poorer overall prognosis.
Intermittent protein restriction before but not after the onset of diabetic kidney disease attenuates disease progression in mice.
Front Nutr
June 2024
NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Article Synopsis
- High dietary protein can worsen kidney issues in people with diabetic kidney disease (DKD), and while low protein diets (LPD) have mixed results, keeping patients on a consistent protein restriction is tough.
- This study tested intermittent protein restriction (IPR) using diabetic KK-Ay mice, alternating days of low and normal protein intake before and after DKD onset, comparing them to a control group on a steady normal diet.
- Findings showed that starting IPR before DKD development reduced kidney damage, while starting it after DKD onset did not help, suggesting that IPR might be a helpful approach for managing DKD and could improve patient adherence to dietary changes.
Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.
Eur J Pediatr
September 2024
Nephrology Unit, Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Albuminuria has been considered the golden standard biomarker for diabetic kidney disease (DKD), but appears once significant kidney damage has already occurred. Angiopoietin-2 (Angpt-2) has been implicated in the development and progression of DKD in adults. We aimed to explore the association of serum Angpt-2 levels with DKD in children and adolescents with type 1 diabetes mellitus (T1DM) of short duration (3-5 years) and to evaluate the predictive power of serum Angpt-2 in the early detection of DKD prior to the microalbuminuric phase.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!